Search - tctmd.com

Displaying 841 - 860 of 874

Sort: Relevancy | Date

News Daily News

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

April 20, 2011

News Daily News

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

Caitlin E. Cox

April 20, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Daily News

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

L.A. McKeown

April 07, 2011

News Conference News

PROTECTION-AMI: Experimental Agent Does Not Prevent Reperfusion Injury

Caitlin E. Cox

April 05, 2011

News Conference News

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

April 05, 2011

News Conference News

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

L.A. McKeown

April 05, 2011

News Conference News

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Caitlin E. Cox

April 05, 2011

News Conference News

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Caitlin E. Cox

April 04, 2011

News Industry News

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

April 04, 2011

News Conference News

For Bifurcations, 1 Stent Just as Good as 2 Out to 5 Years

Jason Kahn

April 03, 2011

News Industry News

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 03, 2011

News Daily News

BARI 2D: Prompt Revascularization Improves Angina Symptoms in Diabetics

L.A. McKeown

April 01, 2011

News Daily News

Clinicians Agree Overall with Appropriateness Criteria, with Some Caveats

March 28, 2011

News Daily News

Bone Marrow Stem Cells Show Positive Results in Small Chronic AMI Trial

Jason Kahn

March 17, 2011

News Daily News

EVAR in Nonagenarians Shows Acceptable Perioperative Mortality

Leah Lawrence

March 15, 2011

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

News Daily News

Nonaccess Site Bleeding After PCI Strongly Tied to Long-term Mortality

March 08, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

Advertisement

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

PROTECTION-AMI: Experimental Agent Does Not Prevent Reperfusion Injury

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

STICH: CABG Does Not Extend Survival Over Medical Therapy in Heart Failure Patients

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

For Bifurcations, 1 Stent Just as Good as 2 Out to 5 Years

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

BARI 2D: Prompt Revascularization Improves Angina Symptoms in Diabetics

Clinicians Agree Overall with Appropriateness Criteria, with Some Caveats

Bone Marrow Stem Cells Show Positive Results in Small Chronic AMI Trial

EVAR in Nonagenarians Shows Acceptable Perioperative Mortality

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

Studies Support DES Use in Diabetics, But Results Vary by Device

Nonaccess Site Bleeding After PCI Strongly Tied to Long-term Mortality

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content